4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-013017
CEO and CFO bought 2,000 shares at $11.12 ($22,240)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-04-18 | Purchase | +2,000 | $11.12 | $22,240 | 5,279,177 | D |
| Open-market purchases · 2,000 sh · avg $11.12 · $22,240 | |||||||
Loading xslF345X04/ownership.xml…